PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.560.02 (-0.36%)
5.56 - 5.56
4.95 - 8.28
45 / 2.4K (Avg.)
-278.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.32%
Negative revenue growth while STERV.HE stands at 1.22%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-7.80%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
86.36%
EBIT growth above 1.5x STERV.HE's 55.67%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
86.36%
Operating income growth above 1.5x STERV.HE's 55.67%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
400.00%
Net income growth above 1.5x STERV.HE's 227.25%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
333.33%
EPS growth above 1.5x STERV.HE's 200.00%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
333.33%
Diluted EPS growth above 1.5x STERV.HE's 200.00%. David Dodd would see if there's a robust moat protecting these shareholder gains.
23.08%
Share count expansion well above STERV.HE's 0.01%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
23.08%
Diluted share count expanding well above STERV.HE's 0.01%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-192.65%
Negative OCF growth while STERV.HE is at 72.73%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-324.78%
Negative FCF growth while STERV.HE is at 196.89%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-13.56%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-13.56%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-13.56%
Negative 3Y CAGR while STERV.HE stands at 19.35%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-179.07%
Negative 10Y OCF/share CAGR while STERV.HE stands at 2995.30%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-179.07%
Negative 5Y OCF/share CAGR while STERV.HE is at 161.55%. Joel Greenblatt would question the firm’s operational model or cost structure.
-179.07%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
160.54%
Positive 10Y CAGR while STERV.HE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
160.54%
5Y net income/share CAGR at 50-75% of STERV.HE's 293.51%. Martin Whitman might see a shortfall in operational efficiency or brand power.
160.54%
Below 50% of STERV.HE's 450.00%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
-3.23%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-3.23%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-3.23%
Negative 3Y equity/share growth while STERV.HE is at 12.88%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.70%
We show growth while STERV.HE is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-2.95%
Negative asset growth while STERV.HE invests at 0.29%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-14.94%
We have a declining book value while STERV.HE shows 0.88%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-3.14%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.